Literature DB >> 19626332

Short-term antibiotics treatment in patients with nasal polyps and enterotoxins producing Staphylococcus aureus strains.

Petr Schalek1, P Petrás, V Klement, A Hahn.   

Abstract

Enterotoxins produced by Staphylococcus aureus (SA) can act as super-antigens and thus influence the course of chronic rhinosinusitis with nasal polyps (NP). The aim of this study was to determine if antibiotic treatment administered after endoscopic sinus surgery (ESS) for NP can positively influence the course of the disease compared to placebo. After ESS, 23 patients who tested positive, in a perioperative culture, for SA strains producing enterotoxins A-E and TSST-1, were randomized into two groups. Group A which in addition to standard treatment received oral anti-staphylococcal antibiotics for 3 weeks. Group B received a placebo. Both groups were compared preoperatively, and at 3 and 6 months after surgery using a symptom-specific score, an endoscopic score and the SNOT-22 quality of life questionnaire. Slightly better results were achieved in patients who received antibiotic therapy. However, the differences were not statistically significant. Regardless of post-operative treatment, approximately 30% of patients had a SA-negative culture 6 months after surgery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19626332     DOI: 10.1007/s00405-009-1049-x

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  25 in total

Review 1.  Staphylococcus aureus enterotoxins: a key in airway disease?

Authors:  C Bachert; P Gevaert; P van Cauwenberge
Journal:  Allergy       Date:  2002-06       Impact factor: 13.146

2.  Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis.

Authors:  Thibaut Van Zele; Philippe Gevaert; Jean-Baptiste Watelet; Geert Claeys; Gabriele Holtappels; Cindy Claeys; Paul van Cauwenberge; Claus Bachert
Journal:  J Allergy Clin Immunol       Date:  2004-10       Impact factor: 10.793

3.  Possible influences of Staphylococcus aureus on atopic dermatitis-- the colonizing features and the effects of staphylococcal enterotoxins.

Authors:  Y Morishita; J Tada; A Sato; Y Toi; H Kanzaki; H Akiyama; J Arata
Journal:  Clin Exp Allergy       Date:  1999-08       Impact factor: 5.018

4.  Fibronectin binding protein and host cell tyrosine kinase are required for internalization of Staphylococcus aureus by epithelial cells.

Authors:  K Dziewanowska; J M Patti; C F Deobald; K W Bayles; W R Trumble; G A Bohach
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

5.  Colonization with superantigen-producing Staphylococcus aureus is associated with increased severity of atopic dermatitis.

Authors:  T M Zollner; T A Wichelhaus; A Hartung; C Von Mallinckrodt; T O Wagner; V Brade; R Kaufmann
Journal:  Clin Exp Allergy       Date:  2000-07       Impact factor: 5.018

6.  Staphylococcus aureus enterotoxin B, protein A, and lipoteichoic acid stimulations in nasal polyps.

Authors:  Joke Patou; Philippe Gevaert; Thibaut Van Zele; Gabriele Holtappels; Paul van Cauwenberge; Claus Bachert
Journal:  J Allergy Clin Immunol       Date:  2007-11-05       Impact factor: 10.793

7.  Internalization of Staphylococcus aureus by endothelial cells induces apoptosis.

Authors:  B E Menzies; I Kourteva
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

8.  Nebulized bacitracin/colimycin: a treatment option in recalcitrant chronic rhinosinusitis with Staphylococcus aureus? A double-blind, randomized, placebo-controlled, cross-over pilot study.

Authors:  W J M Videler; C M van Drunen; J B Reitsma; W J Fokkens
Journal:  Rhinology       Date:  2008-06       Impact factor: 3.681

9.  Internalization of Staphylococcus aureus by endothelial cells induces cytokine gene expression.

Authors:  L Yao; V Bengualid; F D Lowy; J J Gibbons; V B Hatcher; J W Berman
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

10.  Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomised, controlled trial.

Authors:  Sameh M Ragab; Valerie J Lund; Glenis Scadding
Journal:  Laryngoscope       Date:  2004-05       Impact factor: 3.325

View more
  5 in total

Review 1.  Role of medical therapy in the management of nasal polyps.

Authors:  Isam Alobid; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2012-04       Impact factor: 4.806

Review 2.  Diagnosis and Management of Rhinosinusitis: Highlights from the 2015 Practice Parameter.

Authors:  Kathleen Dass; Anju Tripathi Peters
Journal:  Curr Allergy Asthma Rep       Date:  2016-04       Impact factor: 4.806

3.  Comparison of the Oral Steroids, Macrolides and Combination Therapy in Nasal Polyposis Patients.

Authors:  Fatih Tetik; Arzu Yasemin Korkut; Kerem Sami Kaya; Irmak Ucak; Irfan Celebi; Berna Uslu Coskun
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2020-06-12

Review 4.  Systemic and topical antibiotics for chronic rhinosinusitis.

Authors:  Karen Head; Lee Yee Chong; Patorn Piromchai; Claire Hopkins; Carl Philpott; Anne G M Schilder; Martin J Burton
Journal:  Cochrane Database Syst Rev       Date:  2016-04-26

5.  Chronic rhinosinusitis and emerging treatment options.

Authors:  Patorn Piromchai; Pornthep Kasemsiri; Supawan Laohasiriwong; Sanguansak Thanaviratananich
Journal:  Int J Gen Med       Date:  2013-06-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.